| Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer C Twyman-Saint Victor, AJ Rech, A Maity, R Rengan, KE Pauken, ... Nature 520 (7547), 373-377, 2015 | 2296 | 2015 |
| PI3K/AKT/mTOR pathway in angiogenesis J Karar, A Maity Frontiers in molecular neuroscience 4, 51, 2011 | 1321 | 2011 |
| Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade JL Benci, B Xu, Y Qiu, TJ Wu, H Dada, C Twyman-Saint Victor, L Cucolo, ... Cell 167 (6), 1540-1554. e12, 2016 | 1018 | 2016 |
| Regulation of glut1 mRNA by hypoxia-inducible factor-1: interaction between H-ras and hypoxia C Chen, N Pore, A Behrooz, F Ismail-Beigi, A Maity Journal of Biological Chemistry 276 (12), 9519-9525, 2001 | 982 | 2001 |
| Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation H Fujimura, CA Altar, R Chen, T Nakamura, T Nakahashi, J Kambayashi, ... Thrombosis and haemostasis 87 (04), 728-734, 2002 | 943 | 2002 |
| ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth LS Hart, JT Cunningham, T Datta, S Dey, F Tameire, SL Lehman, BO Qiu, ... The Journal of clinical investigation 122 (12), 4621-4634, 2012 | 426 | 2012 |
| The molecular basis for cell cycle delays following ionizing radiation: a review A Maity, WG McKenna, RJ Muschel Radiotherapy and oncology 31 (1), 1-13, 1994 | 397 | 1994 |
| Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving … A Maity, N Pore, J Lee, D Solomon, DM O’Rourke Cancer research 60 (20), 5879-5886, 2000 | 353 | 2000 |
| Design, implementation, and in vivo validation of a novel proton FLASH radiation therapy system ES Diffenderfer, II Verginadis, MM Kim, K Shoniyozov, A Velalopoulou, ... International Journal of Radiation Oncology* Biology* Physics 106 (2), 440-448, 2020 | 348 | 2020 |
| EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1–independent and HIF-1–dependent mechanisms N Pore, Z Jiang, A Gupta, G Cerniglia, GD Kao, A Maity Cancer research 66 (6), 3197-3204, 2006 | 337 | 2006 |
| Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice … MA Brehm, A Cuthbert, C Yang, DM Miller, P DiIorio, J Laning, ... Clinical immunology 135 (1), 84-98, 2010 | 325 | 2010 |
| Nurse and physician barriers to spiritual care provision at the end of life MJ Balboni, A Sullivan, AC Enzinger, ZD Epstein-Peterson, YD Tseng, ... Journal of pain and symptom management 48 (3), 400-410, 2014 | 320 | 2014 |
| Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1–independent mechanism N Pore, S Liu, HK Shu, B Li, D Haas-Kogan, D Stokoe, J Milanini-Mongiat, ... Molecular biology of the cell 15 (11), 4841-4853, 2004 | 291 | 2004 |
| Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults DCH Stripp, A Maity, AJ Janss, JB Belasco, ZA Tochner, JW Goldwein, ... International Journal of Radiation Oncology* Biology* Physics 58 (3), 714-720, 2004 | 283 | 2004 |
| Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation GD Kao, Z Jiang, AM Fernandes, AK Gupta, A Maity Journal of Biological Chemistry 282 (29), 21206-21212, 2007 | 269 | 2007 |
| Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting—the MSKCC experience BS Hoppe, LD Stegman, MJ Zelefsky, KE Rosenzweig, SL Wolden, ... International Journal of Radiation Oncology* Biology* Physics 67 (3), 691-702, 2007 | 264 | 2007 |
| Clinical landscape of oncolytic virus research in 2020 N Macedo, DM Miller, R Haq, HL Kaufman Journal for immunotherapy of cancer 8 (2), 2020 | 263 | 2020 |
| Non-obese diabetic–recombination activating gene-1 (NOD–Rag 1 null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγnull) null mice: a radioresistant … T Pearson, LD Shultz, D Miller, M King, J Laning, W Fodor, A Cuthbert, ... Clinical & Experimental Immunology 154 (2), 270-284, 2008 | 247 | 2008 |
| Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036 WW Chan, SC Wise, MD Kaufman, YM Ahn, CL Ensinger, T Haack, ... Cancer cell 19 (4), 556-568, 2011 | 228 | 2011 |
| Cellular responses to EGFR inhibitors and their relevance to cancer therapy PR Dutta, A Maity Cancer letters 254 (2), 165-177, 2007 | 226 | 2007 |
